|
TMEM133 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85551574105602E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07722727907367E-13 |
| Normal-vs-Stage2 |
1.552870E-04 |
| Normal-vs-Stage3 |
7.3187000004804E-07 |
| Normal-vs-Stage4 |
1.884350E-03 |
| Stage1-vs-Stage2 |
8.206600E-01 |
| Stage1-vs-Stage3 |
1.871590E-01 |
| Stage1-vs-Stage4 |
7.596300E-02 |
| Stage2-vs-Stage3 |
5.005400E-01 |
| Stage2-vs-Stage4 |
2.368200E-01 |
| Stage3-vs-Stage4 |
4.477600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97429858520104E-11 |
| Normal-vs-AfricanAmerican |
9.570000E-04 |
| Normal-vs-Asian |
1.67639999992808E-07 |
| Caucasian-vs-AfricanAmerican |
1.080050E-01 |
| Caucasian-vs-Asian |
5.794300E-02 |
| AfricanAmerican-vs-Asian |
5.153400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40030000039815E-07 |
| Normal-vs-Female |
1.87738713464114E-13 |
| Male-vs-Female |
2.868400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.32910382489149E-11 |
| Normal-vs-Age(41-60Yrs) |
2.22330043264662E-10 |
| Normal-vs-Age(61-80Yrs) |
2.19440000004401E-06 |
| Normal-vs-Age(81-100Yrs) |
1.139020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.778800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.028600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.081600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.365900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.803800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.226400E-02 |
| Classical-VS-Follicular |
3.353600E-02 |
| Classical-VS-Other |
6.005000E-01 |
| Classical-VS-Normal |
1.63125069008174E-12 |
| Tall-VS-Follicular |
9.049000E-01 |
| Tall-VS-Other |
8.489600E-01 |
| Tall-VS-Normal |
6.19179999999941E-05 |
| Follicular-VS-Other |
8.587600E-01 |
| Follicular-VS-Normal |
3.425600E-04 |
| Other-VS-Normal |
1.443640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.38100003549613E-09 |
| Normal-vs-N1 |
8.755500E-04 |
| N0-vs-N1 |
3.246200E-01 |
|
|
